Therapeutic Solutions International EBIT

The latest EBIT for TSOI is $-3.4M as of September 2024. That compares with $-2.2M in the prior-year period — down 51.9% year over year. That is below the Healthcare sector average of $130B. Investors often review this figure alongside Therapeutic Solutions International's historical trend and sector peers before judging valuation or financial health.

Over the past year, TSOI's EBIT moved from $-2.2M to $-3.4M — a 51.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Therapeutic Solutions International's operating scale or balance-sheet position.

Against Healthcare companies, TSOI currently prints $-3.4M for EBIT, while the sector average sits near $130B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Therapeutic Solutions International's growth, margins, and balance sheet.

A EBIT figure of $-3.4M for TSOI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $130B. Explore the charts below for those layers of context.

After noting TSOI's EBIT ($-3.4M), review year-over-year change from $-2.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.